Article Text

Download PDFPDF

2022-RA-760-ESGO Predictive model of severe complications in patients who underwent an open gynecological cancer surgery on an enhanced recovery after surgery (ERAS) program
Free
  1. Diletta Fumagalli1,
  2. Tommaso Grassi2,
  3. Luca Bazzurini2,
  4. Tommaso Bianchi1,
  5. Chiara Procaccianti1,
  6. Mauro Angelo Gili3,
  7. Giampaolo Di Martino2,
  8. Gaetano Trezzi2,
  9. Francesca Vecchione2,
  10. Maria Letizia Di Meo1,
  11. Benedetta Zambetti1,
  12. Desirée de Vicari1,
  13. Valter Torri4 and
  14. Fabio Landoni1
  1. 1University of Milano-Bicocca, Milano, Italy
  2. 2San Gerardo Hospital – Gynecology Unit, Monza, Italy
  3. 3San Gerardo Hospital – Anesthesia and Intensive Care Unit, Monza, Italy
  4. 4Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy

Abstract

Introduction/Background Enhanced Recovery After Surgery (ERAS) is a global multimodal perioperative care initiative designed to achieve early recovery after major surgery. Our primary objective was to analyze the postoperative outcomes after open gynecological cancer surgery on an ERAS program and to design a predictive model of severe complications after surgery.

Methodology We retrospectively reviewed patients undergoing open surgery for suspected gynecological malignancy and managed according to the ERAS guidelines from January 1st, 2019 to December 31st, 2019, at a tertiary-care center in Monza, Italy. Surgical Complexity Score (SCS), Clavien-Dindo Classification (CDC) of complications and a Comprehensive Complication Index (CCI) were applied for each patient. Association between patient-, disease- and surgical-variables and severe postoperative complications (defined as CCI ≥26.2 events) were estimated using a uni- and multivariable logistic regression model. Factors associated with severe postoperative complications were used to construct a predictive model and nomogram.

Results One hundred and fifty-eight patients who underwent an open surgery were included in the study: 86 ovarian, 28 cervical, 39 uterine and 5 non-gynecological cancers. Overall, 8.2% of patients experienced a CDC grade IIIA-V complication, while 13.3% had a CCI ≥26.2. The median CCI was 8.7 [IQR 0–20.9]. Cancer type, number of comorbidities, blood loss during surgery and SCS were independent predictors of severe postoperative complications after open gynecological cancer surgery.

Conclusion The application of an ERAS program in open gynecological cancer surgery is safe and results in an acceptable complication rate. The risk of severe postoperative complications may be predicted using our risk-model. This may help the clinician in personalizing care for each patient. Further prospective evaluations of this model are needed.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.